We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices

By LabMedica International staff writers
Posted on 18 Aug 2026

Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. More...

These limitations can slow diagnosis and restrict use at the bedside or in resource-limited settings. Although phase-based methods can reveal important morphological details, conventional systems often trade accuracy for speed and compactness. Researchers have now developed an ultrathin metasurface approach designed to capture quantitative phase information on smaller sensors, supporting more compact clinical imaging devices.

Researchers at the Australian Research Council Centre of Excellence for Transformative Meta-Optical Systems (TMOS), working across RMIT University and The University of Melbourne, have created a metasurface that supports quantitative phase microscopy (QPM). The device images microscopic objects that are nearly invisible to conventional intensity-based optics. It is designed to enable compact, field-deployable imaging for clinical and research settings.

The metasurface is “nonlocal,” meaning it processes the entire image rather than redirecting individual rays like a lens. Because it can sit directly in front of the sample, it reduces space and alignment demands. It integrates multiple nanostructured elements onto a single ultrathin surface to deliver phase-contrast information with minimal hardware movement.

Quantitative phase microscopy (QPM) requires phase-gradient measurements along two perpendicular directions. Conventional approaches typically obtain these measurements by rotating optical elements or swapping components, adding time and complexity to the imaging workflow. The new design integrates two sets of wavelength-selective nanostructures onto a single surface, allowing users to switch between orthogonal measurements simply by changing the illumination wavelength. The researchers also incorporated differential phase contrast to reduce noise and improve reconstructed phase maps.

Published in Nanophotonics on July 1, 2026, the approach is intended to simplify imaging workflows for conditions in which cell shape and growth patterns are clinically relevant, including sickle cell disease, cancer, and neurodegenerative disorders. The researchers note that near-term challenges include the cost of supporting hardware and fabrication, as well as the need for precisely tuned dual-wavelength illumination. They are also exploring integration with commercial microscopes using an infrared light-emitting diode.

Related Links
TMOS


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.